GORDON CARL L
CIK 1282930
Transactions on file
19
Open-market buys
8
Win rate (buys)
75%
8 scored
Avg % since filing (buys)
+259.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -24.5% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 758,279 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 333,333 | $5.00M | -24.5% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,703,314 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,087,934 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 2,002,310 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | Buy | 625,000 | $10.00M | +34.4% | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,049,283 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,039,996 | $0.00 | — | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Buy | 1,000,000 | $15.00M | +111.3% | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | C | 348,825 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +466.6% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +520.4% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +523.6% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +466.6% | open → |
| 2025-04-11 | 2025-04-09 | CMPX Compass Therapeutics, Inc. | Director10% | Sale | 3,571,428 | $5.68M | -30.2% | open → |
| 2025-06-06 | 2025-06-04 | KROS Keros Therapeutics, Inc. | Director | Grant | 5,250 | $0.00 | — | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 74,465 | $1.32M | -37.0% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 140,057 | $2.49M | -37.0% | open → |
